Edgewise Therapeutics, Inc. EWTX 深 沪
等待开盘 04-01 09:30:00 美东时间
31.50
+1.220
+4.03%
华盛通- 最 高32.46
- 今 开30.67
- 成交量 112.27万股
- 最 低 30.67
- 昨 收 30.28
- 总市值 33.79亿
- 52周最高 32.80
- 市盈率 静 --
- 换手率 1.05%
- 52周最低 11.50
- 委 比 62.64%
- 总股本 1.07亿
- 历史最高 40.49
- 量 比 1.43
- 振 幅 5.91%
- 历史最低 5.12
- 每 手 1
- 风险率 6.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Edgewise CMO Joanne Donovan disposes of $685k common shares
Edgewise CMO Joanne Donovan disposes of $685k common shares Edgewise Therapeutics CMO Joanne M. Donovan sold 21,338 shares on March 31, 2026 at an average price of $32.12. The transaction followed an option exercise of 21,338 shares at $7.08. Donovan held 9,597 shares directly following the transact
今天 09:31
美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价
今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元
03-18 10:48
Wedbush Reiterates Outperform on Edgewise Therapeutics, Maintains $32 Price Target
Wedbush analyst Laura Chico reiterates Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and maintains $32 price target.
03-17 20:25
The $3B Biotech With Two Shots On Goal
A cleaner drug, zero competition, and two binary readouts this year. Plus, Powell and oil near $99.
03-17 19:07
U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson
U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson March 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biogen, Eli Lilly and Johnson & Johnson on Tuesday. HIGHLIGHTS * Biogen BIIB.O : HSBC raises target pri
03-17 15:31
Edgewise Therapeutics Presents At 2026 MDA Clinical And Scientific Conference, Long-Term Data From MESA Open-Label Extension Study Of Sevasemten In Becker Muscular Dystrophy
–The MESA data show stabilization of function in participants on sevasemten versus the predicted functional decline observed in Becker natural history studies –– Data reinforce prior clinical findings of sevasemten in
03-10 19:15
Edgewise’s New EDG-7500 Study Signals Broader Cardiovascular Ambitions
Edgewise Therapeutics, Inc. ($EWTX) announced an update on their ongoing clinic...
03-07 00:32
Edgewise Therapeutics Reports Inducement Stock Option Grants Under Nasdaq Rules
Edgewise Therapeutics Reports Inducement Stock Option Grants Under Nasdaq Rules Edgewise Therapeutics said it granted inducement stock options covering 51,000 shares to three new non-executive employees under its 2024 Inducement Equity Incentive Plan. The options have an exercise price of $30.44 per
03-02 22:30
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
Evercore ISI Group Maintains Outperform on Edgewise Therapeutics, Raises Price Target to $45
Evercore ISI Group analyst Cory Kasimov maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and raises the price target from $30 to $45.
02-27 21:57
